Locus -Model CRISPR-Cas3 -Gene Editing Platform

CRISPR-Cas3 offers a unique approach to human genome editing with the ability to produce long-range deletions. Our IP portfolio enables the use of Cas3 human gene editing, a capability that we have been incubating since the inception of Locus. The ability to produce long-range deletions makes it possible to inactivate and/or remove of undesirable genetic material (e.g., viral genomes). Cas3 genome editing offers us another unique tool in its pursuit of using precision medicines to revolutionize the treatment of disease.